DE69715625D1 - Arzneipräparat zur behandlung der gastritis, der reflux-ösophagitis, duodenitis,dyspepsie und ulkuserkrankungen - Google Patents
Arzneipräparat zur behandlung der gastritis, der reflux-ösophagitis, duodenitis,dyspepsie und ulkuserkrankungenInfo
- Publication number
- DE69715625D1 DE69715625D1 DE69715625T DE69715625T DE69715625D1 DE 69715625 D1 DE69715625 D1 DE 69715625D1 DE 69715625 T DE69715625 T DE 69715625T DE 69715625 T DE69715625 T DE 69715625T DE 69715625 D1 DE69715625 D1 DE 69715625D1
- Authority
- DE
- Germany
- Prior art keywords
- reflux
- alginate
- duodenitis
- ösophagitis
- dyspepsy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000007882 Gastritis Diseases 0.000 title abstract 2
- 206010013864 duodenitis Diseases 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 abstract 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 abstract 2
- 229940072056 alginate Drugs 0.000 abstract 2
- 235000010443 alginic acid Nutrition 0.000 abstract 2
- 229920000615 alginic acid Polymers 0.000 abstract 2
- 230000008029 eradication Effects 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- KKMOSYLWYLMHAL-UHFFFAOYSA-N 2-bromo-6-nitroaniline Chemical compound NC1=C(Br)C=CC=C1[N+]([O-])=O KKMOSYLWYLMHAL-UHFFFAOYSA-N 0.000 abstract 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 abstract 1
- 241000589876 Campylobacter Species 0.000 abstract 1
- 208000025865 Ulcer Diseases 0.000 abstract 1
- 239000011324 bead Substances 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 229910052797 bismuth Inorganic materials 0.000 abstract 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 abstract 1
- 235000010410 calcium alginate Nutrition 0.000 abstract 1
- 239000000648 calcium alginate Substances 0.000 abstract 1
- 229960002681 calcium alginate Drugs 0.000 abstract 1
- 239000001110 calcium chloride Substances 0.000 abstract 1
- 229910001628 calcium chloride Inorganic materials 0.000 abstract 1
- 229940043430 calcium compound Drugs 0.000 abstract 1
- 150000001674 calcium compounds Chemical class 0.000 abstract 1
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 abstract 1
- 239000007795 chemical reaction product Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 201000006549 dyspepsia Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000005187 foaming Methods 0.000 abstract 1
- 210000004211 gastric acid Anatomy 0.000 abstract 1
- 208000021302 gastroesophageal reflux disease Diseases 0.000 abstract 1
- 210000003736 gastrointestinal content Anatomy 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000006386 neutralization reaction Methods 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 239000012429 reaction media Substances 0.000 abstract 1
- 238000010992 reflux Methods 0.000 abstract 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 abstract 1
- 235000017557 sodium bicarbonate Nutrition 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9601219A SE507682C2 (sv) | 1996-03-29 | 1996-03-29 | Farmaceutisk beredning för behandling av gastrit, refluxesofagit, duodenit, dyspepsi och magsårssjukdom innehållande en blandning av ammoniumvismutcitrat och ett alginat |
| PCT/SE1997/000544 WO1997036599A1 (en) | 1996-03-29 | 1997-03-27 | Pharmaceutical preparation for the treatment of gastritis, reflux oesophagitis, duodenitis, dyspepsia and ulcer disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69715625D1 true DE69715625D1 (de) | 2002-10-24 |
| DE69715625T2 DE69715625T2 (de) | 2003-06-12 |
Family
ID=20402012
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69715625T Expired - Fee Related DE69715625T2 (de) | 1996-03-29 | 1997-03-27 | Arzneipräparat zur behandlung der gastritis, der reflux-ösophagitis, duodenitis,dyspepsie und ulkuserkrankungen |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0910388B1 (de) |
| JP (1) | JP2000507572A (de) |
| AT (1) | ATE224197T1 (de) |
| AU (1) | AU2525397A (de) |
| DE (1) | DE69715625T2 (de) |
| ES (1) | ES2184081T3 (de) |
| PL (1) | PL329152A1 (de) |
| RU (1) | RU2193407C2 (de) |
| SE (1) | SE507682C2 (de) |
| WO (1) | WO1997036599A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9621273D0 (en) | 1996-10-11 | 1996-11-27 | Cortecs Ltd | Therapeutic method |
| US6117868A (en) * | 1998-09-16 | 2000-09-12 | Ed. Geistlich Sohne Ag Fur Chemische Industrie | Treatment of gastrointestinal ulcers or gastritis caused by microbial infection |
| US7732404B2 (en) | 1999-12-30 | 2010-06-08 | Dexcel Ltd | Pro-nanodispersion for the delivery of cyclosporin |
| GB0012487D0 (en) * | 2000-05-24 | 2000-07-12 | Pfylori Limited | Use of metal compounds to treat gastrointestinal infections |
| AU2002356493A1 (en) * | 2001-11-19 | 2003-06-10 | Nobel Ilac Sanayii Ve Ticaret A.S. | New pharmaceutical combinations prepared with alginates and biphosphonates in order to prevent gastroesophageal reflux during use of oral biphoshonates |
| AU2005237246A1 (en) * | 2004-04-30 | 2005-11-10 | Nycomed Gmbh | Method of classifying GERD |
| JP2006342085A (ja) * | 2005-06-08 | 2006-12-21 | Kao Corp | Gip分泌抑制剤 |
| CN102558383B (zh) * | 2012-01-10 | 2014-07-23 | 中国科学院海洋研究所 | 一种海藻酸铋及其制备方法和应用 |
| CN104524356A (zh) * | 2014-12-11 | 2015-04-22 | 吴燕 | 一种治疗返流性食道炎的中药组合物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU179474B (en) * | 1978-02-24 | 1982-10-28 | Laszlo Gyarmati | Process for preparing solid oral pharmaceutical compositons with increased length of activity and with a regulated release of the active material |
| NZ205076A (en) * | 1982-08-09 | 1985-04-30 | Univ California | Protecting and healing gastro-duodenal mucosa and the liver of mammals using a fatty acid |
| DE3615710A1 (de) * | 1986-05-09 | 1987-11-26 | Hoechst Ag | Zubereitungen fuer die synthese von prostaglandinen und hydroxyfettsaeuren in biologischen systemen |
| EP0348143A3 (de) * | 1988-06-21 | 1991-03-13 | MARION LABORATORIES, INC. (a Delaware corporation) | Bismuth-Derivate von Saccharid-Phosphaten und Sulfaten |
| GB8819110D0 (en) * | 1988-08-11 | 1988-09-14 | Norsk Hydro As | Antihypertensive drug & method for production |
| NL9220019A (nl) * | 1992-04-10 | 1994-04-05 | Vnii Med Polimerov | Farmaceutische samenstelling. |
| BR9507199A (pt) * | 1994-03-24 | 1997-09-09 | Procter & Gamble Cellulose | Formas de dose sólidas contendo bismuto |
-
1996
- 1996-03-29 SE SE9601219A patent/SE507682C2/sv not_active IP Right Cessation
-
1997
- 1997-03-27 DE DE69715625T patent/DE69715625T2/de not_active Expired - Fee Related
- 1997-03-27 WO PCT/SE1997/000544 patent/WO1997036599A1/en active IP Right Grant
- 1997-03-27 ES ES97916696T patent/ES2184081T3/es not_active Expired - Lifetime
- 1997-03-27 PL PL97329152A patent/PL329152A1/xx unknown
- 1997-03-27 EP EP97916696A patent/EP0910388B1/de not_active Expired - Lifetime
- 1997-03-27 JP JP9535200A patent/JP2000507572A/ja active Pending
- 1997-03-27 AU AU25253/97A patent/AU2525397A/en not_active Abandoned
- 1997-03-27 RU RU98119709/14A patent/RU2193407C2/ru not_active IP Right Cessation
- 1997-03-27 AT AT97916696T patent/ATE224197T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| SE507682C2 (sv) | 1998-07-06 |
| ATE224197T1 (de) | 2002-10-15 |
| PL329152A1 (en) | 1999-03-15 |
| EP0910388B1 (de) | 2002-09-18 |
| SE9601219D0 (sv) | 1996-03-29 |
| RU2193407C2 (ru) | 2002-11-27 |
| ES2184081T3 (es) | 2003-04-01 |
| AU2525397A (en) | 1997-10-22 |
| SE9601219L (sv) | 1997-09-30 |
| EP0910388A1 (de) | 1999-04-28 |
| DE69715625T2 (de) | 2003-06-12 |
| JP2000507572A (ja) | 2000-06-20 |
| WO1997036599A1 (en) | 1997-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW403629B (en) | Powders providing controlled sustained release of a gas | |
| ES2265645T3 (es) | Composiciones biocidas transparentes de liberacion prolongada. | |
| US4978528A (en) | Process for preventing degradation of an anti-bacterial composition | |
| KR101537774B1 (ko) | 악취제거제 조성물 및 그 제조방법 | |
| DE69715625D1 (de) | Arzneipräparat zur behandlung der gastritis, der reflux-ösophagitis, duodenitis,dyspepsie und ulkuserkrankungen | |
| CA2436825A1 (en) | Process for the crystallization of (r)- or (s)-lansoprazole | |
| JP2907299B2 (ja) | 胃酸を結合する薬学的製剤 | |
| DE3684409D1 (de) | Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eubnes arzneimittels zur behandlung von endometriose. | |
| AU2571199A (en) | Silicate-containing powders providing controlled, sustained gas release | |
| IL104959A0 (en) | Sulfur-containing aromatic compounds,process for the preparation thereof and pharmaceutical compositions containing the same | |
| EP0611163B1 (de) | Polymere biozide Zusammensetzung und Verfahren zu ihrer Herstellung | |
| NO913684L (no) | Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer. | |
| ATE12791T1 (de) | Kurzkettige oligosaccharide mit biologischen eigenschaften, verfahren zu ihrer herstellung und ihre verwendungen als arzneimittel. | |
| RU98119709A (ru) | Фармацевтические препараты для лечения гастритов, рефлюксэзофагитов, дуоденитов, диспепсии и язвы | |
| KR850004393A (ko) | 경구 투여용 지효성(遲效性) 아세틸살리실산 제제 | |
| KR100338491B1 (ko) | 인중합체로 된 흉터 억제 및 상처 회복 촉진제 | |
| ATE50492T1 (de) | Stabilisierung von unbestaendigen arzneimitteln und nahrungszusaetzen. | |
| TNSN03081A1 (en) | Composition containing paraquat and/or diquat, an alginate and an emetic and/or purgative | |
| NO961638L (no) | Gelatinkapselfyllstoff som kan skumme | |
| ATE205093T1 (de) | Produkt zur behandlung von tierischen exkrementen | |
| PT1250291E (pt) | Agente de melhoramento da agua contendo algas coralinas | |
| NO913683L (no) | Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer. | |
| RU94046300A (ru) | Химические соединения, способ их получения, фармкомпозиция, способ лечения, промежуточный продукт | |
| DE69915301D1 (de) | Verfahren zur herstellung einer körnigen porösen trockenen gelzusammensetzung von sucralfate | |
| HU913009D0 (en) | Method for producing inhibitors of calcium ingestion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |